These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA. Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451 [Abstract] [Full Text] [Related]
5. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML. J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719 [Abstract] [Full Text] [Related]
13. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome. De La Roca RL, Da Cunha IW, Bezerra SM, Da Fonseca FP. Int Braz J Urol; 2014 Sep; 40(3):306-15. PubMed ID: 25010296 [Abstract] [Full Text] [Related]
14. Early surgical results with intent to treat by radical retropubic prostatectomy for clinically localized prostate cancer. Abbas F, Siddiqui K, Biyabani SR, Hasan SH, Talati J. J Pak Med Assoc; 2002 May; 52(5):200-5. PubMed ID: 12174491 [Abstract] [Full Text] [Related]
18. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era. Dorin RP, Lieskovsky G, Fairey AS, Cai J, Daneshmand S. Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714 [Abstract] [Full Text] [Related]